Sector News

Bunge and BP to form a bioenergy JV

July 22, 2019
Chemical Value Chain

Bunge (New York, NY), a leading producer and supplier of oilseed and grain products and ingredients, announced a partnership with BP plc (London, UK), the world’s sixth-largest oil and gas production and distribution company, to form a 50-50 ethanol joint venture in the north and Midwest regions of Brazil.

The net proceeds Bunge will gain from the transaction will be used to reduce the company’s credit facilities debt.

The joint venture, called BP Bunge Bioenergia, will consist of 11 mills with 32 million metric tons of combined crushing capacity per year to produce a mix of ethanol and sugar. The bioenergy company will also generate renewable electricity, fueled by waste biomass from the sugar cane, through its cogeneration facilities to power its sites and sell electricity to the Brazilian power grid. The venture is to be headquartered in Sao Paolo. Mario Lindenhayn (BP) will be the executive chairman and Geovane Consul (Bunge) will be the CEO of the new company. BP and Bunge will have equal representation on the board of directors.

By Akshita Bhatia

Source: Chemical Week

3 responses to “Bunge and BP to form a bioenergy JV

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 10, 2021

TechnipFMC resumes plans to split company

Chemical Value Chain

TechnipFMC says it has resumed activities related to the previous announced separation of the company into two separate pure-play businesses, TechnipFMC and Technip Energies.

January 10, 2021

Solvay’s extended maternity, paternity & co-parent policy goes into effect

Chemical Value Chain

Solvay’s new policy increases maternity leave to 16 weeks. It is now available to any co-parent regardless of gender or sexual orientation; it also includes parents who adopt. The parent employed by Solvay will receive 100% of his or her salary during this leave period.

January 10, 2021

Solvay to sell its North American and European amphoteric surfactant business 

Chemical Value Chain

The Solvay Group (Brussels, Belgium) agreed to sell its North American and European amphoteric surfactant business to OpenGate Capital, a private equity firm with headquarters in Los Angeles. The sale includes the three main production sites in University Park, Illinois (USA), Genthin, Germany, Halifax, United Kingdom, and a tolling business in Turkey.

Send this to a friend